Yang VC - Search Results

1

Synthetic skin-permeable proteins enabling needleless immunization.

Huang Y, Park YS, Moon C, David AE, Chung HS, Yang VC. Huang Y, et al. Among authors: yang vc. Angew Chem Int Ed Engl. 2010 Apr 1;49(15):2724-7. doi: 10.1002/anie.200906153. Angew Chem Int Ed Engl. 2010. PMID: 20232417 Free PMC article. No abstract available.

2

Controlled release of clot-dissolving tissue-type plasminogen activator from a poly(L-glutamic acid) semi-interpenetrating polymer network hydrogel.

Park Y, Liang J, Yang Z, Yang VC. Park Y, et al. Among authors: yang vc, yang z. J Control Release. 2001 Jul 10;75(1-2):37-44. doi: 10.1016/s0168-3659(01)00360-1. J Control Release. 2001. PMID: 11451495

3

Nontoxic membrane translocation peptide from protamine, low molecular weight protamine (LMWP), for enhanced intracellular protein delivery: in vitro and in vivo study.

Park YJ, Chang LC, Liang JF, Moon C, Chung CP, Yang VC. Park YJ, et al. Among authors: yang vc. FASEB J. 2005 Sep;19(11):1555-7. doi: 10.1096/fj.04-2322fje. Epub 2005 Jul 20. FASEB J. 2005. PMID: 16033808 Free article.

4

A GPIIb/IIIa bioreactor for specific treatment of immune thrombocytopenic purpura, an autoimmune disease. Preparation, in vitro characterization, and preliminary proof-of-concept animal studies.

Emregul E, David A, Balthasar JP, Yang VC. Emregul E, et al. Among authors: yang vc. J Biomed Mater Res A. 2005 Dec 1;75(3):648-55. doi: 10.1002/jbm.a.30470. J Biomed Mater Res A. 2005. PMID: 16108027

5

Strategies for improving the functionality of an affinity bioreactor.

Wang T, Yang Z, Emregul E, David A, Balthasar JP, Liang J, Yang VC. Wang T, et al. Among authors: yang vc, yang z. Int J Pharm. 2005 Dec 8;306(1-2):132-41. doi: 10.1016/j.ijpharm.2005.09.011. Epub 2005 Oct 24. Int J Pharm. 2005. PMID: 16246511

6

Chemically surface modified gel (CSMG): an excellent enzyme-immobilization matrix for industrial processes.

David AE, Wang NS, Yang VC, Yang AJ. David AE, et al. Among authors: yang vc, yang aj. J Biotechnol. 2006 Sep 18;125(3):395-407. doi: 10.1016/j.jbiotec.2006.03.019. Epub 2006 Apr 27. J Biotechnol. 2006. PMID: 16644049

7

A novel polyrotaxane-based intracellular delivery system for camptothecin: in vitro feasibility evaluation.

Moon C, Kwon YM, Lee WK, Park YJ, Chang LC, Yang VC. Moon C, et al. Among authors: yang vc. J Biomed Mater Res A. 2008 Jan;84(1):238-46. doi: 10.1002/jbm.a.31452. J Biomed Mater Res A. 2008. PMID: 17607767

8

Glioma selectivity of magnetically targeted nanoparticles: a role of abnormal tumor hydrodynamics.

Chertok B, David AE, Huang Y, Yang VC. Chertok B, et al. Among authors: yang vc. J Control Release. 2007 Oct 8;122(3):315-23. doi: 10.1016/j.jconrel.2007.05.030. Epub 2007 Jun 2. J Control Release. 2007. PMID: 17628157 Free PMC article.

9

In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide.

Moon C, Kwon YM, Lee WK, Park YJ, Yang VC. Moon C, et al. Among authors: yang vc. J Control Release. 2007 Dec 4;124(1-2):43-50. doi: 10.1016/j.jconrel.2007.08.029. Epub 2007 Sep 5. J Control Release. 2007. PMID: 17904680 Free PMC article.

10

Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors.

Chertok B, Moffat BA, David AE, Yu F, Bergemann C, Ross BD, Yang VC. Chertok B, et al. Among authors: yang vc. Biomaterials. 2008 Feb;29(4):487-96. doi: 10.1016/j.biomaterials.2007.08.050. Epub 2007 Oct 26. Biomaterials. 2008. PMID: 17964647 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters